Technical Insights

Pentoxyverine HCl Crystallization: Acid Impurity Impact

Pentoxyverine Hydrochloride Crystallization: How 1-Phenylcyclopentanecarboxylic Acid Impurity Alters Crystal Habit and Filtration Rates

Chemical Structure of 1-Phenylcyclopentanecarboxylic acid (CAS: 77-55-4) for Pentoxyverine Hydrochloride Crystallization: Acid Impurity Impact On Crystal Habit & Filtration RatesIn the synthesis of pentoxyverine hydrochloride, the final crystallization step is critical for achieving the desired purity, particle size distribution, and downstream processability. A key impurity that can significantly influence the crystallization outcome is 1-phenylcyclopentanecarboxylic acid (CAS 77-55-4), also known as 1-phenylcyclopentane-1-carboxylic acid or PCCA. This organic acid intermediate is a structural fragment of the pentoxyverine molecule and can be present as a residual starting material or degradation byproduct. Even at low levels, this impurity can alter the crystal habit of the API, shifting it from a desirable compact morphology to an acicular (needle-like) form that drastically reduces filtration rates and complicates drying. Understanding this phenomenon is essential for process chemists and R&D managers aiming to maintain consistent manufacturing performance.

Our team at NINGBO INNO PHARMCHEM CO.,LTD. has extensive field experience with this impurity. We have observed that in certain solvent systems, the presence of 1-phenylcyclopentyl carboxylic acid at concentrations above 0.5% can induce a habit modification from plate-shaped to needle-like crystals. This is consistent with the principles discussed in the literature, where crystal habit modification is shown to depend on the nature of impurities and their interaction with specific crystal faces (see Crystal Growth and Design, 2013, 13, 2824–2832). For a deeper dive into the coupling reaction where this impurity originates, refer to our article on solvent incompatibility and exotherm control during amide coupling.

Technical Specifications and COA Parameters for 1-Phenylcyclopentanecarboxylic Acid (CAS 77-55-4) as a Critical Process Impurity

When sourcing 1-phenylcyclopentanecarboxylic acid for use as a reference standard or for process development, it is crucial to understand the typical specifications that ensure batch-to-batch consistency. As a chemical building block in the synthesis route of pentoxyverine, its purity directly impacts the final API quality. Below is a comparison of typical industrial grades available from NINGBO INNO PHARMCHEM CO.,LTD., which can serve as a drop-in replacement for other suppliers. For a detailed comparison with a major competitor, see our article on drop-in replacement for Oakwood Chemical 1-phenylcyclopentanecarboxylic acid.

ParameterTechnical GradePharma Grade
Purity (HPLC)≥ 98.5%≥ 99.5%
Melting Point158–162°C159–161°C
Loss on Drying≤ 0.5%≤ 0.2%
Residue on Ignition≤ 0.2%≤ 0.1%
Heavy Metals≤ 20 ppm≤ 10 ppm
AppearanceWhite to off-white crystalline powderWhite crystalline powder

Please refer to the batch-specific COA for exact values. Our factory supply adheres to strict quality assurance protocols, and we provide comprehensive documentation to support your manufacturing process.

Impact of Acid Impurity on Crystal Morphology: From Acicular to Plate-Shaped Habits and Their Effect on Downstream Processing

The crystal habit of an API is a critical quality attribute that affects filtration, washing, drying, and even dissolution performance. In the case of pentoxyverine hydrochloride, the presence of 1-phenylcyclopentanecarboxylic acid can selectively inhibit or promote growth on certain crystal faces. This is due to the anisotropic surface chemistry of the different facets. The carboxylic acid group of the impurity can hydrogen-bond with specific functional groups on the growing crystal surface, leading to a change in the relative growth rates of the faces. As demonstrated in the study on celecoxib (see Crystal Growth and Design, 2013), a plate-shaped habit exhibited faster dissolution and higher bioavailability compared to an acicular habit because of more abundant hydrophilic surfaces. Similarly, in pentoxyverine HCl, an acicular habit caused by the acid impurity can lead to poor filterability and slow drying, while a plate-shaped habit is preferred for efficient downstream processing.

From our field experience, a non-standard parameter to monitor is the viscosity of the crystal slurry at low temperatures. When the impurity induces needle formation, the slurry can exhibit a significant increase in apparent viscosity below 10°C, making transfer and filtration more difficult. This is often overlooked in standard specifications but can be a key indicator of habit issues. Additionally, trace levels of the impurity can cause a slight yellow discoloration in the final API if not adequately purged during washing, which is another edge-case behavior we have documented.

Optimizing Filtration and Drying: Practical Strategies for Handling Crystal Habit Variations in Pentoxyverine HCl Production

To mitigate the negative impact of acicular crystals on filtration rates, several practical strategies can be employed. First, controlling the cooling profile during crystallization can help. A slower cooling rate often promotes the growth of more equant crystals. Second, the choice of solvent system is paramount. Adding a small amount of a polar aprotic solvent can sometimes disrupt the preferential adsorption of the impurity on fast-growing faces. Third, seeding with pure pentoxyverine HCl crystals of the desired habit can help override the impurity effect. Finally, if needle formation is unavoidable, using a filter aid or a pressure filter with a slow ramp-up can prevent blinding of the filter medium.

Drying acicular crystals also requires care. Their high aspect ratio leads to a large surface area that can retain solvent, and they are prone to breakage, generating fines. A vacuum dryer with gentle agitation or a fluidized bed dryer is often more suitable than a tray dryer. Monitoring the residual solvent level by GC is essential to ensure it meets specifications.

Bulk Packaging and Supply Chain Reliability for 1-Phenylcyclopentanecarboxylic Acid: IBC and 210L Drum Solutions

For industrial-scale procurement of 1-phenylcyclopentanecarboxylic acid, NINGBO INNO PHARMCHEM CO.,LTD. offers flexible packaging options to suit your production needs. Our standard packaging includes 25 kg fiber drums, but for larger volumes, we provide 210L steel drums and intermediate bulk containers (IBCs). These packaging solutions are designed to maintain product integrity during storage and transport. Our global manufacturer status ensures a reliable supply chain, and we can accommodate bulk price inquiries for tonnage quantities. All shipments are accompanied by a certificate of analysis (COA) and material safety data sheet (MSDS).

Frequently Asked Questions

What is the typical minimum order quantity (MOQ) for 1-phenylcyclopentanecarboxylic acid?

Our standard MOQ is 1 kg for sample evaluation. For commercial orders, we can supply from 25 kg to multi-ton quantities. Please contact our sales team for a tailored quote.

Can you provide a certificate of analysis (COA) with every batch?

Yes, every shipment includes a batch-specific COA detailing purity, melting point, loss on drying, residue on ignition, heavy metals, and appearance. Additional tests can be performed upon request.

What is the shelf life of 1-phenylcyclopentanecarboxylic acid?

When stored in a cool, dry place in the original unopened container, the product has a recommended retest date of 2 years from the date of manufacture.

Do you offer custom synthesis or impurity profiling services?

While our core business is the supply of high-purity intermediates, we can discuss custom synthesis projects for related compounds. Please reach out with your specific requirements.

Sourcing and Technical Support

As a leading supplier of 1-phenylcyclopentanecarboxylic acid, NINGBO INNO PHARMCHEM CO.,LTD. is committed to supporting your process development and scale-up activities. Our technical team can provide guidance on handling, storage, and integration into your synthesis route. We understand the criticality of impurity control in API manufacturing and strive to deliver consistent industrial purity that meets your GMP standard requirements. Ready to optimize your supply chain? Reach out to our logistics team today for comprehensive specifications and tonnage availability.